Envista Holdings NVST
NYSE NVST
$27.20 +0.27 (+1.00%)
At close: Aug 21, 2026 · 4:00 PM EDT

Envista Holdings (NVST) Cash from Investing Activities (2018 - 2026)

Envista Holdings (NVST) posted quarterly Cash from Investing Activities of -$68.9 million for Q2 2026, down 682.95% year-over-year from $11.8 million in Q2 2025, and down 344.52% quarter-over-quarter from -$15.5 million in Q4 2025.

Envista Holdings (NVST) Cash from Investing Activities (2018 - 2026) Analysis & Trends

Envista Holdings' Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$68.9 million for Q2 2026.

  • In Q2 2026, Cash from Investing Activities fell 682.95% year-over-year to -$68.9 million; the TTM figure through Apr 2026 stood at -$111.2 million (down 111.01% YoY), while the FY2025 annual figure was -$51.1 million, up 6.41% from the prior year.
  • Cash from Investing Activities for Q2 2026 stood at -$68.9 million, down from -$15.5 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $5.1 million in Q2 2022, with the low at -$591.6 million in Q3 2022.
  • The 5-year median for Cash from Investing Activities is -$12.6 million (2023), against an average of -$52.6 million.
  • Peak annual rise in Cash from Investing Activities reached 192.73% in 2022, while the deepest fall reached 3319.65% in 2022.
  • Envista Holdings' Cash from Investing Activities stood at -$1.1 million in 2022, then tumbled by 1045.45% to -$12.6 million in 2023, then soared by 41.27% to -$7.4 million in 2024, then plunged by 109.46% to -$15.5 million in 2025, then tumbled by 344.52% to -$68.9 million in 2026.
  • Business Quant data shows NVST's Cash from Investing Activities at -$68.9 million in Q2 2026, -$15.5 million in Q4 2025, and -$9.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -26.60 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -241.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -222.00 Mn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -383.65 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -461.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -43.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -87.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -90.00 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -117.00 Mn
10 Envista Holdings 4.40 Bn 3.27 Bn 407.00 Mn -14.30 Mn

Historic Data

Download Data
DateValue
Jul 3, 2026 -14.30 Mn
Jul 3, 2026 -14.30 Mn
Apr 3, 2026 -68.90 Mn
Apr 3, 2026 -68.90 Mn
Dec 31, 2025 -15.50 Mn
Dec 31, 2025 -15.50 Mn
Sep 26, 2025 -9.70 Mn
Sep 26, 2025 -9.70 Mn
Jun 27, 2025 -17.10 Mn
Jun 27, 2025 -17.10 Mn
Mar 28, 2025 -8.80 Mn
Mar 28, 2025 -8.80 Mn
Dec 31, 2024 -7.40 Mn
Dec 31, 2024 -7.40 Mn
Sep 27, 2024 -30.60 Mn
Sep 27, 2024 -30.60 Mn
Jun 28, 2024 -5.90 Mn
Jun 28, 2024 -5.90 Mn
Mar 29, 2024 -10.70 Mn
Mar 29, 2024 -10.70 Mn